Evaluation of Semaphorin 3G (SEMA3G) as a biofluid biomarker of cerebral amyloid angiopathy: evidence from neurodegenerative disease and memory clinic cohorts
Introduction: Cerebral amyloid angiopathy (CAA) is characterised by amyloid-beta (Aβ) deposition in cerebral vessels, and frequently co-occurs with Alzheimer's disease (AD). Diagnosis based on MRI-based Boston criteria is not definitive, and CAA biofluid biomarkers are needed. Semaphorin 3G (SEMA3G) was recently shown to be selectively enriched in CAA-affected vessels, and correlated with CAA severity. We therefore evaluated SEMA3G as a biofluid biomarker of CAA. Methods: SEMA3G profiles were examined across diagnoses in the Global Neurodegeneration Proteomics Consortium dataset (GNPC) in cerebrospinal fluid (CSF) (N=1982) and plasma (N=6917). SEMA3G was then evaluated in the Healthy Brain Ageing (HBA) memory clinic cohort (N=161) with 3T MRI, where lobar cerebral microbleed burden was used as a proxy for CAA likelihood, with participants grouped by microbleed count (0, 1-2, or ≥3). Results: CSF and plasma SEMA3G were significantly lower in AD and frontotemporal dementia (FTD) compared to cognitively unimpaired controls in GNPC, and were associated with hypertension. Longitudinally, plasma SEMA3G declined significantly over time in mild cognitive impairment (MCI) and AD. In the HBA cohort, plasma SEMA3G did not differ by cerebral microbleed burden on MRI, nor correlate with plasma Aβ isoforms and white matter hyperintensities. Discussion : Although CSF and plasma SEMA3G levels were significantly lower in AD and FTD, plasma SEMA3G was not associated with CAA-associated MRI features in individuals at risk of AD. While these findings do not support plasma SEMA3G for identifying individuals with higher CAA-associated burden, its potential utility warrants further evaluation in genetically susceptible or neuropathologically confirmed CAA cohorts.
Authors
- Johannes C. Michaelian (ORCID: https://orcid.org/0000-0001-5683-8222)
- Eleanor Drummond (ORCID: https://orcid.org/0000-0002-5466-4609)
- Dongang Wang (ORCID: https://orcid.org/0000-0001-5805-0244)
- Sharon Linda Naismith (ORCID: https://orcid.org/0000-0001-9076-2778)
- Lisa Shi (ORCID: https://orcid.org/0009-0007-9826-4424)
- Michael Harry Barnett (ORCID: https://orcid.org/0000-0002-2156-8864)
- Chenyu Wang (ORCID: https://orcid.org/0000-0001-7135-7662)
Institutions
- The University of Sydney (AU)
Publication Details
- Journal
- medRxiv
- Published
- 2026-11-20
- DOI
- https://doi.org/10.64898/2026.11.18.26368450
- Primary Topic
- Intracerebral and Subarachnoid Hemorrhage Research
- Type
- preprint